Form 4: Elanco Animal Health Executive James M. Meer Reports Changes in Beneficial Ownership

James M. Meer, Chief Accounting Officer of Elanco Animal Health Inc., reports acquisition of restricted stock units and disposition of shares to cover tax liabilities.

Summary

• On March 1, 2024, James M. Meer, Chief Accounting Officer of Elanco Animal Health Inc., acquired 9,046 shares of common stock through a grant of restricted stock units.
• These restricted stock units vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
• On the same day, Meer disposed of 1,667 shares of common stock at a price of $16.03 to cover tax liabilities associated with the vesting of previously awarded restricted stock units.
• Following these transactions, Meer beneficially owns 50,347 shares of Elanco Animal Health Inc. common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the filing reflects standard executive compensation practices and tax-related transactions.

Positives

• The acquisition of restricted stock units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and contribution to Elanco's success.

Future Outlook

The executive's holdings are tied to the future performance of Elanco Animal Health, incentivizing value creation.

Industry Context

Executive stock transactions are common in the animal health industry as a way to align management incentives with shareholder value.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation adjustments.

Key Dates